Navigation Links
Accuray Recognized for Delivering 'World-Class' Customer Service

SUNNYVALE, Calif., Feb. 29, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it has received the NorthFace ScoreBoard Award(SM) (NFSB Award) from Omega Management Group Corp. (Omega) in recognition of achieving excellence in customer service and support in 2011. In addition to getting exceptional ratings for customer satisfaction, Accuray is the first organization also to qualify for outstanding customer loyalty based on its Net Promoter ScoreTM (NPS) under a new NFSB-NPS methodology Omega announced on Dec. 6, 2011.

Since 2000, the NFSB Award has been presented annually to companies that, as rated solely by their own customers, exceeded expectations in customer service and support during the prior calendar year.

"The NorthFace ScoreBoard Award recognizes organizations that not only offer exemplary customer service, but who also center their existence on a deep commitment to exceeding customer expectations," said John Alexander Maraganis, founder, president and CEO of Omega. "There is no award designed specifically for NPS users that recognizes such achievement at this high level, so we are pleased to welcome Accuray to the elite group of NFSB Award recipients."

"We are pleased to be recognized by our customers and are honored to be the first company to receive the NorthFace ScoreBoard award for exceeding customer expectations for satisfaction plus high customer loyalty scores, two very different yet equally important metrics," said Euan S. Thomson, Ph.D., president and CEO of Accuray. "As we continue to grow our global presence, we remain committed to providing exceptional support and service to our customers toward our shared goal of improving the lives of cancer patients."

Omega's proprietary NFSB Award methodology measures customer satisfaction and loyalty levels on a 5-point scale a minimum of four times during a calendar year in such categories as technical support, field service, customer service and account management.  Companies must achieve a score of 4.0 or above from their customers to receive the NFSB Award. The Net Promoter Score relies on answers to a single question: "How likely is it that you would recommend Accuray to a friend or colleague"? The responses are interpreted on scale of zero to 10 where zero is "not at all likely to recommend" and 10 is "extremely likely to recommend." Omega's NFSB-NPS conversion methodology is used to audit NPS users for the NFSB Award.

"Due to its unique 'customer-only vote' criteria, the NorthFace ScoreBoard Award has been viewed from its inception as the only objective benchmark for excellence in customer service," Maraganis said. "Our research indicates that companies that consistently achieve a 4.0 rating or above, which we call the 'Loyalty Zone,' are succeeding in locking in profitable, long-term customer relationships, and this significantly raises the bar on their competitors."

About Omega Management Group Corp.

Founded in 1984, Omega is a pioneer and recognized expert in developing and implementing customer experience management (CEM) strategy programs that lead to increased product and service revenue and profits.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. The Company's leading edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, more than 300,000 patients worldwide have been treated using the Company's technologies and more than 616 systems have been installed in leading hospitals around the world. For more information, please visit

Safe Harbor Statement

Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, expansion of the Company's global presence. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations, including risks detailed from time to time under the heading "Risk Factors" in the Company's report on Form 10-K for fiscal year 2011, and its reports on Form 10-Q for the first and second quarters of fiscal 2012.

Forward-looking statements speak only as of the date the statements are made and are based on information available to the Company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The Company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.  Accordingly, investors should not place undue reliance on any forward-looking statements.

All trademarks, service marks and company names are the property of their respective owners.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Euan S. Thomson, Ph.D.

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Incorporateds CEO to Speak at Cowen and Company 32nd Annual Healthcare Conference
2. Accuray Incorporated to Speak at Citi 2012 Global Health Care Conference
3. Accuray Incorporated to Speak at 14th Annual Needham Growth Conference
4. Medical Centers Worldwide Adopt Both Accurays CyberKnife and TomoTherapy Systems
5. Accuray Incorporated to Speak at 22nd Annual Oppenheimer Healthcare Conference
6. Accuray Receives Outstanding Innovative Improvement Award for its CyberKnife System
7. Accuray Incorporateds CEO to Speak at Lazard Capital Markets 8th Annual Healthcare Conference and Stephens Fall Investment Conference
8. Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
9. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012
10. Accuray Ranked 274th Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
11. Accuray Unveils CyberKnife and TomoTherapy Product Enhancements and Service Offerings at ASTRO 2011
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):